NEW YORK (GenomeWeb News) - Ikonisys has hired Louise Mawhinney to the post of senior VP and chief financial officer, the cell-based diagnostics developer said this week. Mawhinney formerly was a senior VP and CFO of Helicos Biosciences, and before that she was a CFO at ArQule, and at Cleanwise, and the Butcher Company.
Lentigen has appointed Jim Meade to be VP of corporate development. Meade has worked at Avalon Pharmaceuticals as VP of business development, and he has a total of 30 years experience at companies including Pharmacia, Bayer, and Chiron.
Michael Callaghan has resigned from Vermillion’s board of directors, the company stated in a filing with the US Securities and Exchange Commission this week.
Callaghan was a member of the company’s audit and compensation committees of the board of directors. The company said Callaghan resigned for personal reasons and not as the result of any disagreement.
Invitrogen announced that it has named Mark Smedley, the firm’s global head of operations, to lead the integration team for its $6.7 billion acquisition of Applied Biosystems.
RXi Pharmaceuticals has appointed University of Massachusetts scientist Victor Ambros to its scientific advisory board. Ambros is best known for his work in discovering microRNA. He was a professor at Dartmouth College from 1992 to 2007, and before that he studied genetic pathways as a post-doctoral fellow at the Massachusetts Institute of Technology.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.